Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan F Cowman

Showing results (211-220 of 232) with videos related to

Pageof 24
Sort By:
Journal of Medicinal Chemistry|February 22, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4Trent D Ashton, Madeline G Dans, Paola Favuzza, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
Scientific Reports|July 18, 2019
A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4Paul R Gilson, Rasika Kumarasingha, Jennifer Thompson, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
JCI Insight|June 15, 2021
High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malariaLisa J Ioannidis, Halina M Pietrzak, Ann Ly, et al.
Nature Communications|April 15, 2026
GID/CTLH E3 ligase complex control cell fate programs for sexual development of Plasmodium falciparumDanushka S Marapana, Sash Lopaticki, Balu Balan, et al.
ACS Infectious Diseases|July 9, 2026
2-Amino-3,4-Dihydroquinazolines Exhibit Potent Antimalarial Activity by Targeting Plasmepsin XMadeline G Dans, Jon Kyle Awalt, Nghi Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker developmentJack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Pageof 24

Showing results (211-220 of 232) with videos related to

Sort By:
Pageof 24
Journal of Medicinal Chemistry|February 22, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4Trent D Ashton, Madeline G Dans, Paola Favuzza, et al.
Elife|September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine developmentCamila Tenorio França, Michael T White, Wen-Qiang He, et al.
Scientific Reports|July 18, 2019
A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4Paul R Gilson, Rasika Kumarasingha, Jennifer Thompson, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Frontiers in Cellular and Infection Microbiology|January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical settingJulie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
JCI Insight|June 15, 2021
High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malariaLisa J Ioannidis, Halina M Pietrzak, Ann Ly, et al.
Nature Communications|April 15, 2026
GID/CTLH E3 ligase complex control cell fate programs for sexual development of Plasmodium falciparumDanushka S Marapana, Sash Lopaticki, Balu Balan, et al.
ACS Infectious Diseases|July 9, 2026
2-Amino-3,4-Dihydroquinazolines Exhibit Potent Antimalarial Activity by Targeting Plasmepsin XMadeline G Dans, Jon Kyle Awalt, Nghi Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker developmentJack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Pageof 24